| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bio-Techne Corp (TECH) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TECH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 124.1K | $5.57M | - | |
| CEO | 61.7K | $2.77M | - | |
| Dir | 46.5K | $2.09M | - | |
| Dir | 44.6K | $2.00M | - | |
| Dir | 15.4K | $691.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2019 | Hippel James74 | Chief Financial Officer | Sale+OE | 35,000 | $203.08 | $7,107,681.00 | -88.9% | |
| Aug 24, 2018 | Baumgartner Robert V52 | Director | Sale+OE | 5,000 | $188.47 | $942,333.50 | -39.3% | |
| Aug 23, 2018 | Higgins John L66 | Director | Sale+OE | 10,000 | $187.92 | $1,879,173.00 | -76.9% | |
| Aug 8, 2018 | Dinarello Charles A | Director | Sale+OE | 5,000 | $176.94 | $884,675.00 | -37.8% | |
| Jun 7, 2018 | Kummeth Charles R.74 | Chief Executive Officer | Sell | 8,000 | $160.00 | $1,280,000.00 | -9.5% | |
| May 4, 2018 | Eansor Norman David52 | SVP - Novus Biologicals | Sell | 1,136 | $145.19 | $164,931.75 | -33.4% | |
| Feb 13, 2018 | Dinarello Charles A | Director | Sale+OE | 5,000 | $136.06 | $680,303.00 | -20.9% | |
| Nov 1, 2017 | Baumgartner Robert V52 | Director | Sale+OE | 5,000 | $130.18 | $650,907.00 | -39.3% | |
| Oct 10, 2017 | Lucas Roger C | Director | Sell | 100 | $121.96 | $12,195.50 | -5.1% | |
| Sep 8, 2017 | Lucas Roger C | Director | Sell | 100 | $120.94 | $12,093.83 | -4.8% |